Concepedia

R. Blom

RB

Statistics

Publications

6

Citations

746

H-Index

6

Active since

1988

Affiliations

Leiden University(Current)

Nordic Society of Gynecologic Oncology

Beatson West of Scotland Cancer Centre

European Organisation for Research and Treatment of Cancer

Odense University Hospital

R. Blom is an author at Leiden University specializing in vaccination, tumor immunity, and t cell immunity.

Top concepts

Publications per year

1988–2003

6

Publications

6

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

René E. M. Toes, Rienk Offringa, R. Blom et al. · Proceedings of the National Academy of Sciences · 1996 · 292 citations · Full text

, , +20

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors

René E. M. Toes, R. Blom, Rienk Offringa et al. · The Journal of Immunology · 1996 · 209 citations

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

Martine Piccart, K. Bertelsen, Gavin Stuart et al. · International Journal of Gynecological Cancer · 2003 · 122 citations

An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated <i>ras</i> oncogene.

René E. M. Toes, Rienk Offringa, R. Blom et al. · The Journal of Immunology · 1995 · 62 citations

Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart, K. Bertelsen, Gavin Stuart et al. · International Journal of Gynecological Cancer · 2003 · 35 citations

1–5 of 6